skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I've looked on SEDAR for information on the purchase of Catamaran by United Health. Everything I've read gives the purchase price in US$. Nothing I've read says anything about the TSX-traded shares. Should I infer that, in the event the deal goes through, CA$-purchased shares would be exchanged for US$ - with a currency-conversion hit - such that it were preferable to journal one's holdings in a US$ account? Is there a general rule about this sort of thing? Thanks.
Read Answer Asked by John on April 20, 2015
Q: I'm pushing the edge with this question (so feel free to reject it) but do you have a US stock you like, with a decent dividend and some potential for growth? I'm sitting on US cash that I'd like to use for dividend income over the medium term, but would like to see a bit of growth when I cash it out. Thanks!
Read Answer Asked by Kate on April 15, 2015
Q: I have a large position in this company and because of the share price increase its now 15% of my portfolio. I have done a lot of due diligence. Normally I don't allow one holding to have this much weight but I have found that there are rare instances where I am prepared to hold my position. I recognize that everyone has a different comfort level but is there ever a case where you would allow this great a weighting?
Read Answer Asked by Murray on April 15, 2015
Q: would like a comment on today's 1Q15 sales,eps and outlook. thanks
Read Answer Asked by george on April 15, 2015
Q: Got an analyist upgrade to-day.Your thoughts on this company please.Thanks.
Read Answer Asked by maurice on April 15, 2015
Q: Peter have just sold my Catamaran...am looking to stay in the same sector I already own GUD + PHM + MRE...do you have any suggestions. Staying with a health care provider would be first choice (I think) I am about 4% invested in the sector.
Read Answer Asked by Terence on April 14, 2015
Q: Merus made a move yesterday involving 60 million dollars. Do you see this as a good move and is it worth adding stock to my position?

Thanks, Charlie
Read Answer Asked by Charlie on April 14, 2015
Q: I have a question regarding the recently upsized bought deal of $58.5M. In the past, I have felt as though many "upsized" deals come about due to external demand and promotion by the underwriting syndicate to company management. This can be a negative as the incremental capital raised likely has no immediate place to go(otherwise, why not start at the higher sized offering to begin with...), and this can result in shareholder dilution.

I realize PHM is a role up company and currently on an acquisition spree so this may not apply to them but what do you make of this increased deal size? I worry about all the extra dilution.

Thanks.
Read Answer Asked by Scott on April 13, 2015
Q: Hi folks,can please get update on Merus labs and finace @ $3.05,where would u rank the stock in relation to other Cdn biotech comps;buy,hold or sell.Thanks as always jb
Read Answer Asked by John on April 13, 2015
Q: Would you recommend GUD over CXR for a 5-7 year hold? I feel like I might be chasing CXR at this point and that GUD has more upside (with the risk of being a smaller cap).

Thanks, Neil
Read Answer Asked by Neil on April 13, 2015
Q: I recently bought Cipher on its pullback. ? thoughts on today's announced acquisition of US private pharmaceutical Innocutis. Market seems to like it a lot.
Thanks
Read Answer Asked by richard on April 13, 2015
Q: I notice this Co. on the new highs list.
May I have your opinion please.
Read Answer Asked by claudette on April 11, 2015
Q: Three insiders have bought recently, but it has no revenue and is only in phase two trials. Do they have enough money to continue, or is this just a hope that someone will buy them? If it works, they're worth a fortune.
Read Answer Asked by John on April 11, 2015
Q: Each Subscription Receipt will entitle the holder thereof to receive, upon the closing of the Acquisition, without payment of additional consideration or further action, one Concordia common share in exchange for each Subscription Receipt.

Why companies sell subscription receipts instead os shares? Should I buy the shares or the receipts?

Regards

Read Answer Asked by Claude on April 11, 2015
Q: Yesterday, a member asked if we could see any news about RX.V. The company "advises that it is not aware of any material undisclosed business development that should account for the decrease in its stock price". Source: http://www.stockhouse.com/news/press-releases/2015/04/10/biosyent-comments-on-recent-market-activity. The stock is now up 9%.
Read Answer Asked by Matt on April 10, 2015
Q: I own just a few shares of Concordia. . Would a few hundred shares bought in my rrsp at these prices make sense. It just keeps climbing.
Read Answer Asked by Helen on April 10, 2015
Q: Pli closed today at $ 2.72 - how much of the price do you think is related to speculation regarding the upcoming level 2 drug trials and do they have sufficient funds to complete the trials or wifi they require an equity raise? Many thanks
Read Answer Asked by Tom on April 10, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!